Subvisible Particles in IVIg Formulations Activate Complement in Human Serum
Journal Article
Overview
publication date
- January 1, 2020
has subject area
- Acute-Phase Proteins - Complement C3
- Anaphylatoxins - Complement C5a
- Blood Proteins - Immunoglobulins, Intravenous
- Chemical Phenomena - Freezing
- Complement Activation
- Complement C5 - Complement C5a
- Complement System Proteins
- Complement System Proteins - Complement C3
- Complement System Proteins - Complement Factor B
- Drug Compounding
- Drug Industry - Drug Packaging
- Endopeptidases - Complement Factor B
- Enzymes and Coenzymes - Complement Factor B
- Globulins - Immunoglobulins, Intravenous
- Humans
- Immunoproteins - Immunoglobulins, Intravenous
- Immunoproteins - Immunoglobulins, Intravenous
- Investigative Techniques - Drug Packaging
- Particle Size
- Physical Phenomena - Freezing
- Product Packaging - Drug Packaging
- Protein Aggregates
- Protein Precursors - Complement Factor B
- Serine Proteases - Complement Factor B
- Stress, Mechanical
- Syringes
- Thermodynamics - Freezing
has restriction
- green
Date in CU Experts
- November 5, 2019 6:15 AM
Full Author List
- Chisholm CF; Behnke W; Pokhilchuk Y; Frazer-Abel AA; Randolph TW
author count
- 5
citation count
- 12
published in
Other Profiles
International Standard Serial Number (ISSN)
- 0022-3549
Electronic International Standard Serial Number (EISSN)
- 1520-6017
Digital Object Identifier (DOI)
Additional Document Info
start page
- 558
end page
- 565
volume
- 109
issue
- 1